Daniel B Kopans1. 1. 1 Departments of Radiology, Harvard Medical School and Massachusetts General Hospital, Avon Comprehensive Breast Evaluation Center, ACC Ste 240, 15 Parkman St, Boston, MA 02114.
Abstract
OBJECTIVE: The purpose of this article is to describe the development of digital breast tomosynthesis (DBT) and to describe its advantages over 2D mammography for breast cancer screening. CONCLUSION: Mammographic screening has dramatically reduced breast cancer deaths, but it does not depict all cancer early enough to result in a cure. In addition, because of the recall rates associated with mammography, efforts are underway to reduce access to screening. Use of DBT improves sensitivity and specificity, and there is no longer a need to obtain full-exposure 2D mammograms. DBT will replace standard 2D mammography for breast cancer screening.
OBJECTIVE: The purpose of this article is to describe the development of digital breast tomosynthesis (DBT) and to describe its advantages over 2D mammography for breast cancer screening. CONCLUSION: Mammographic screening has dramatically reduced breast cancer deaths, but it does not depict all cancer early enough to result in a cure. In addition, because of the recall rates associated with mammography, efforts are underway to reduce access to screening. Use of DBT improves sensitivity and specificity, and there is no longer a need to obtain full-exposure 2D mammograms. DBT will replace standard 2D mammography for breast cancer screening.
Authors: Bernhard B Zimmermann; Bin Deng; Bhawana Singh; Mark Martino; Juliette Selb; Qianqian Fang; Amir Y Sajjadi; Jayne Cormier; Richard H Moore; Daniel B Kopans; David A Boas; Mansi A Saksena; Stefan A Carp Journal: J Biomed Opt Date: 2017-04-01 Impact factor: 3.170